Abigail Patrick
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Anesthesia and Sedative Agents
Papers in
-
- Cardiac, Anesthesia and Surgical Outcomes 4
-
- COVID-19 Clinical Research Studies 3
Abigail Patrick
13 papers receiving 1.7k citations
Abigail Patrick's Hit Papers
Peers
Comparison fields: 5 of 95
- Infectious Diseases 715
- Anesthesiology and Pain Medicine 199
- Applied Microbiology and Biotechnology 34
- Emergency Medical Services 80
- Internal Medicine 27
Countries citing papers authored by Abigail Patrick
This map shows the geographic impact of Abigail Patrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abigail Patrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abigail Patrick more than expected).
Fields of papers citing papers by Abigail Patrick
This network shows the impact of papers produced by Abigail Patrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abigail Patrick. The network helps show where Abigail Patrick may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 2 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 3 | Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study Hit paper breakdown → | 2018 | 275 |
| 4 | 2021 | 213 | |
| 5 | Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial Hit paper breakdown → | 2020 | 181 |
| 6 | 2019 | 137 | |
| 7 | 2017 | 112 | |
| 8 | Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial Hit paper breakdown → | 2025 | 94 |
| 9 | 2023 | 43 | |
| 10 | 2019 | 20 | |
| 11 | 2017 | 16 | |
| 12 | 2024 | 9 | |
| 13 | 2023 | 6 |
About Abigail Patrick
Abigail Patrick is a scholar working on Cardiology and Cardiovascular Medicine, Infectious Diseases, Surgery, Emergency Medical Services and Anesthesiology and Pain Medicine, having authored 13 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cardiac, Anesthesia and Surgical Outcomes (4 papers), COVID-19 Clinical Research Studies (3 papers), Hemodynamic Monitoring and Therapy (2 papers), Anesthesia and Sedative Agents (1 paper), Global Health and Surgery (1 paper), Enhanced Recovery After Surgery (1 paper), Patient Safety and Medication Errors (1 paper) and Health Policy Implementation Science (1 paper). The work is most often cited by research in Infectious Diseases (715 citations), Anesthesiology and Pain Medicine (199 citations), Applied Microbiology and Biotechnology (34 citations), Emergency Medical Services (80 citations) and Internal Medicine (27 citations). Abigail Patrick has collaborated with scholars based in United Kingdom, Vietnam and United States. Their work appears in journals such as The Lancet, British Journal of Anaesthesia, The Lancet Respiratory Medicine, European Heart Journal and Trials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.